Atricure announces 2018 analyst and investor meeting
Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in treatments for atrial fibrillation (afib) and left atrial appendage (laa) management, will host an analyst and institutional investor meeting on tuesday, june 26, 2018, in new york city from 8:30 a.m. to approximately 10:00 a.m. eastern time. the meeting will focus on clinician guest speakers to provide expert perspectives on broad trends in cardiac surgery and electrophysiology, key clinical trials, and the collaboration between physicians to best treat afib. featured speakers: marc gillinov, m.d., chairman of the department of thoracic and cardiovascular surgery at the cleveland clinic and surgical director of the center for atrial fibrillation at the cleveland clinic david de lurgio, m.d., electrophysiologist at emory and the principal investigator for atricure’s converge trial marc gerdisch, m.d., chief of cardiovascular and thoracic surgery and co-director of the heart valve center and trial fibrillation program at franciscan st. francis health a live audio webcast of the presentation may be accessed by visiting the investors page of atricure’s corporate website at ir.atricure.com. a replay of the presentation will be available for 90 days following the presentation. about atricure atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 125,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
ATRC Ratings Summary
ATRC Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission